Chinese COVID vaccine maker Clover Biopharma set for HKEX debut


Source: smartkarma.com smartkarma.com

Key Topics in this News Article:

News Snapshot:

Excerpt: … of $1.99 billion.Clover posted a net loss of 912.9 million yuan ($142.58 million) last year due largely to its drug development expenses.Shifara Samsudeen, an analyst with LightStream Research in Sri Lanka who publishes on the SmartKarma platform, … Nikkei Asian Review – Business • (Opens in a new window) ⧉ Are you a Professional Journalist? The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on...